Results 1 to 5 of 6
Most popular |Most recent

Unprecedented State Law on Pharmaceutical “Reverse Payments” Goes Into Effect

USA - January 8 2020 A new California law, Preserving Access to Affordable Drugs, AB-824 (the Act), which is aimed at curbing reverse-payment patent settlements, took…

Christina Luo, Mark A. Ford.

FDA Publishes List of Drug Companies Accused of Hindering Generic Entry: Antitrust Implications

USA - May 17 2018 Today, as part of the Trump Administration's stated goal to lower drug prices, the Food and Drug Administration (FDA) published a list of…

Holly Ovington, Mark A. Ford.

District Court Rejects Direct Purchaser Class for Failure to Satisfy Numerosity Requirement

USA - August 30 2017 On August 28, 2017, in King Drug Company of Florence, Inc., et al. v. Cephalon, Inc., et al., the Eastern District of Pennsylvania denied class…

Holly Ovington, Mark A. Ford.

Death Knell to Merger Litigation for Massachusetts Corporations?

USA - March 13 2017 In IBEW Local No. 129 Benefit Fund v. Tucci, the Massachusetts Supreme Judicial Court (SJC) affirmed the dismissal of direct claims for breach of…

Adam Cambier, Daniel W. Halston.

3rd Circ. Weighs In On Product-Hopping

USA - November 3 2016 On Sept. 28, 2016, in Mylan Pharmaceuticals Inc. v. Warner Chilcott Public Limited Co. (Doryx), the Third Circuit affirmed the lower court's grant…

Ben Ernst, Mark A. Ford.